$NOW

30 New 4-Star Stocks This Week

Morningstar identified 30 US-listed stocks as newly undervalued, including ServiceNow (NOW), Booking Holdings (BKNG), British American Tobacco (BTI), Stryker (SYK), and General Dynamics (GD). These stocks now have a 4-star rating, with prices below their fair value estimates. The US stock market is moderately undervalued, according to Morningstar.

Original reporting
Published Sep 14, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 5:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefSector analysis
Primary signal
$NOW
Bullish
medium confidence
Mentioned
$NOW · $BKNG · $BTI · $SYK · $GD
Relevance
6/10
AlphAI data visualization · based on morningstar.com
Decision brief

The 30-second read

$NOWBullishMed
01

Why it matters

The upgrades signal potential buying opportunities for value investors, though high uncertainty for some names tempers enthusiasm.

02

Market read

The list may drive short‑term inflows into the highlighted stocks and affect sector weightings in value‑oriented portfolios.

03

What to watch

High uncertainty ratings for ServiceNow and Booking suggest earnings volatility that could offset valuation appeal.

Relevance 6/10Novelty 6/10Timing: weekly update

Background

Morningstar’s weekly screen identifies newly undervalued stocks based on price relative to fair‑value estimates and assigns 4‑star ratings.

Company-level read

Ticker impact

$NOWBullishMedium confidence
Context

ServiceNow was upgraded to a 4‑star Morningstar rating after a 6.18% weekly drop, indicating it is now considered undervalued.

Expected impact

Moderate upside if valuation reverts.

Evidence & confidence

Rating upgrade signals undervaluation; price may rise toward fair value.

$BKNGBullishMedium confidence
Context

Booking Holdings received a 4‑star rating after a 9.80% weekly decline, placing it 20% below its fair‑value estimate.

Expected impact

Potential rebound toward fair value.

Evidence & confidence

Rating upgrade combined with discount suggests upside potential.

$BTINeutralLow confidence
Context

British American Tobacco was upgraded to a 4‑star rating, trading 12% below its fair‑value estimate after a modest weekly decline.

Expected impact

Limited upside given modest discount.

Evidence & confidence

Small price move and modest discount limit upside.

$SYKBullishMedium confidence
Context

Stryker moved to a 4‑star rating after a 9.10% weekly loss, now 13% below its fair‑value estimate.

Expected impact

Possible recovery toward fair value.

Evidence & confidence

Rating upgrade plus discount suggests upside potential.

$GDNeutralLow confidence
Context

General Dynamics received a 4‑star rating after a 0.97% weekly decline, trading 13% below its fair‑value estimate.

Expected impact

Modest upside potential.

Evidence & confidence

Small price move and modest discount limit impact.

Market effects

Highlights undervalued opportunities across software, travel, tobacco, medical devices, and defense sectors.

U.S. and global equity markets may see modest buying pressure in the listed sectors.

Rating changes could influence portfolio rebalancing for value‑focused funds worldwide.

Counterpoint

Rating upgrades may be premature if broader market sentiment remains bearish, limiting upside.

Key entities

  • Morningstar

    Provides rating methodology and fair‑value estimates.

Related articles

$SYKHighAI 8/10

Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS

Stryker (SYK) shares fell $26.70 (-8.8%) on Sept. 8, 2026, after its CFO revealed persisting manufacturing issues in its Peripheral Vascular unit, acquired from Inari Medical. The firm Hagens Berman is investigating potential disclosure violations. The issue, initially thought resolved, led to lost sales and backorders, with the CFO stating it will continue into Q4.

$BKNGMed

Booking Holdings Stock Falls as Morgan Stanley Dismisses AI Threat

Booking Holdings (BKNG) stock fell despite Morgan Stanley initiating coverage with an Overweight rating and a $230 price target, arguing AI is an opportunity, not a threat. The bank highlighted BKNG's unique properties and direct booking mix. Morgan Stanley expects online travel bookings to grow 7% annually from 2026-2030. BKNG's Q2 results showed growth in room nights and gross bookings, with raised cost-savings targets.

$BALow

Gaza: Don’t Look Away

President Trump approved a $2.8 billion sale of heavy bombs to Israel, including 40,000 one-ton bombs, 20,000 2,000 lb. bombs, and 20,000 bunker-busting warheads. The weapons will replenish Israel's stockpile, which has been used in Gaza, the West Bank, and Lebanon. Human rights groups have condemned the use of these bombs, citing their impact on civilians and infrastructure. The sale involves U.S. defense contractors Boeing, Lockheed Martin, RTX, General Dynamics, and Northrup Grumman.

$BKNGMed

This stock is Morgan Stanley’s preferred online travel pick in new sector coverage

Morgan Stanley initiated coverage of online travel agencies, rating Booking Holdings (Overweight, $230 PT), Airbnb (Equal-weight, $170 PT), and Expedia (Underweight, $235 PT). The bank favors companies with unique inventory and strong direct traffic, citing AI's potential to drive high-value traffic. Morgan Stanley expects online travel bookings to grow at a 7% CAGR from 2026 to 2030, with fragmented supply becoming more valuable.